Varicella prevention in the United States: a review of successes and challenges.
about
Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adultsMicrobiology laboratory and the management of mother-child varicella-zoster virus infectionDissecting the indirect effects caused by vaccines into the basic elementsReview of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project dataEpidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic reviewVaricella zoster vaccines and their implications for development of HSV vaccinesGenome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factorEnzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosisDysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection.The impact of varicella vaccination on varicella-related hospitalization rates: global data reviewPrevention strategies for herpes zoster and post-herpetic neuralgiaThe natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.Hospitalization due to varicella in the NetherlandsAn outbreak of varicella among schoolchildren in Taipei.Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella.The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey.Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in Taiwan.The controversy of varicella vaccination in children with acute lymphoblastic leukemia.Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011Three-dimensional normal human neural progenitor tissue-like assemblies: a model of persistent varicella-zoster virus infectionDisease burden of herpes zoster in Sweden--predominance in the elderly and in women - a register based studyClinical manifestations of herpes zoster, its comorbidities, and its complications in north of iran from 2007 to 2013Impact of the US Two-dose Varicella Vaccination Program on the Epidemiology of Varicella Outbreaks: Data from Nine States, 2005-2012.Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zosterHerpes zoster ophthalmicus in an otherwise healthy 2-year-old child.Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.Varicella zoster virus in American Samoa: seroprevalence and predictive value of varicella disease history in elementary and college studentsImpact of a routine two-dose varicella vaccination program on varicella epidemiology.Antibody induced by one-dose varicella vaccine soon became weak in children: evidence from a cross-sectional seroepidemiological survey in Beijing, PRCContinuing Decline in Varicella Incidence After the 2-Dose Vaccination Recommendation-Connecticut, 2009-2014.Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.Varicella paediatric hospitalisations in Belgium: a 1-year national surveyHerpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections.Asthma and risk of breakthrough varicella infection in children.Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era.Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study.Efficacy of varicella (VZV) vaccination: an update for the clinician.Pathogenesis and current approaches to control of varicella-zoster virus infections.
P2860
Q24193819-7600AE9F-059F-42B8-AC6E-419B11AF798BQ26738745-D0457C4E-D98B-4D5A-AB03-1671F92F6160Q26799527-9E4B79B3-FDC7-49EB-A6B9-8C592E5E4C0BQ26863614-60451613-91E6-4886-A59D-4CBA59762167Q28080274-E038CB52-6C4D-4C10-BDC7-9E5E00B0EF7EQ28280820-5B6BFEB1-AD48-4057-B630-148CDDF43374Q28474768-9F1632C7-7491-4BDA-B172-C3D36DB8FBD0Q30431538-2DAA1647-A45D-49AE-B23D-178409B6CDA8Q30832346-E7C20C7A-F476-4A2E-9F49-90F89E696907Q31056695-6B1B5F48-FFCB-4C52-B672-78B97CBA2D9BQ33562809-B05A7FAD-E85E-490D-B588-30F8230B6183Q33703581-9E662FA5-AD3A-4AD1-A736-4CDBBDD41302Q33863210-019C1791-AF17-4718-AD76-E281FB582944Q33870506-0DB1F3AC-45F1-4217-9949-FD77967E0598Q34074644-8E10BF9C-3399-441D-8BFF-8693C6629E4FQ34076833-01E30BDB-2553-4CA4-AE47-852145ADB9A8Q34103886-2E574395-067E-43CD-98E5-A6C910FAAB48Q34419709-52196AFC-E97B-40AE-9C68-CBB8D2A6B9E2Q34683751-CAC27D50-3F57-4527-9E7E-F6BD16E5716FQ34788015-C4A7E601-9A5F-409D-819E-C2274832BBA3Q34916815-06B4B6CA-EC51-4894-812A-A0FDA153FB9DQ35065255-DEB8A748-D793-4304-89B6-DE44B18D085AQ35373216-E9FF1155-0D1D-447D-ACA3-529972E134CBQ35694421-AC9699D5-6D6B-4364-80A2-F7F7EBAF32D0Q35942988-C115BD78-5A70-49D8-8443-8A3878BEDB57Q35979111-AC10F60A-FD9D-4B2E-87CA-8BACA26508E8Q36149754-FF518DB9-51DB-406F-BD91-AAC699448580Q36181383-6A39281B-0A9F-456D-80C3-986093B4B6C8Q36206514-06C1A526-48CB-47B8-8EF3-CAF843027E0AQ36270547-12DE0367-40FD-4D3B-92B8-8D01D784E458Q36297495-ED38DB8E-F0DE-4798-AF8B-5426EDA97419Q36369132-CC5E8DB8-92FD-491D-A08C-5BAA4DE28634Q36475701-2789F12A-5FBC-4C02-8095-32C02AEAD34BQ36824210-CB2C9457-C9AE-4EC7-B677-5A019A358CFFQ36841455-B8B04D4C-2787-46A2-89DA-7BEF74E6AF67Q36898125-250DE443-8210-49B6-B6B4-C0110272FFF9Q36960080-A4FE096C-172A-48A9-A454-1E4D1E07E4C0Q37055042-383B10A8-EB17-45BE-B549-614C7A2EA7DDQ37158220-A29C304B-9662-40D5-8F13-9E444989FCA9Q37263293-1A34991B-8603-472B-83EF-B121BD609239
P2860
Varicella prevention in the United States: a review of successes and challenges.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Varicella prevention in the United States: a review of successes and challenges.
@en
Varicella prevention in the United States: a review of successes and challenges.
@nl
type
label
Varicella prevention in the United States: a review of successes and challenges.
@en
Varicella prevention in the United States: a review of successes and challenges.
@nl
prefLabel
Varicella prevention in the United States: a review of successes and challenges.
@en
Varicella prevention in the United States: a review of successes and challenges.
@nl
P2093
P356
P1433
P1476
Varicella prevention in the United States: a review of successes and challenges.
@en
P2093
H Cody Meissner
Jane F Seward
Mona Marin
P304
P356
10.1542/PEDS.2008-0567
P407
P577
2008-09-01T00:00:00Z